Program death receptor-1 (PD-1) and its ligand, program death ligand 1 (PD-L1), mediate immune tolerance PD-L1 is typically expressed on cancer cells, parenchymal and myeloid cells, whereas PD-1 is expressed on activated T cells [5, 6]. The gene discussed is PDCD1; the disease is cancer.